BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 4610047)

  • 21. Antibody formation in mouse bone marrow. III. Effects of route of priming and antigen dose.
    Benner R; Meima F; Van der Meulen GM; van Ewijk W
    Immunology; 1974 Nov; 27(5):747-60. PubMed ID: 4611907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A mechanism for the unresponsive state in BALB-c mice after repeated doses of sheep erythrocytes.
    Thomson PD; Jutila JW
    J Immunol; 1972 Oct; 109(4):742-8. PubMed ID: 4627508
    [No Abstract]   [Full Text] [Related]  

  • 23. Efficacy testing of oral bacterial vaccines by localized haemolysis in gel.
    Thilo W; Seeger E; Schlosshardt J
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):41-4. PubMed ID: 4613139
    [No Abstract]   [Full Text] [Related]  

  • 24. Influence of different doses of antigen in primary immunization on formation of PFC and RFC in the primary and secondary responses.
    Halasa J; Podkowińska I; Braun J; Fidorowicz D
    Arch Immunol Ther Exp (Warsz); 1973; 21(5):709-14. PubMed ID: 4589298
    [No Abstract]   [Full Text] [Related]  

  • 25. Influence of repeated administration of antigen by the oral route on specific antibody-producing cells in the mouse spleen.
    André C; Bazin H; Heremans JF
    Digestion; 1973; 9(2):166-75. PubMed ID: 4589323
    [No Abstract]   [Full Text] [Related]  

  • 26. Antibodies of different immunoglobulin classes released by single cells.
    Storb U; Weiser RS
    J Reticuloendothel Soc; 1972 Mar; 11(3):218-28. PubMed ID: 4555796
    [No Abstract]   [Full Text] [Related]  

  • 27. Antibody plaque responses of mice given Vibrio cholerae antigen as neonates.
    Sajid MA; McAlack RF; Cerny J; Friedman H
    J Immunol; 1971 May; 106(5):1301-5. PubMed ID: 4930067
    [No Abstract]   [Full Text] [Related]  

  • 28. [The effect of BCG on antibody producing mouse cells].
    Gryschek G
    Allerg Immunol (Leipz); 1973; 19(2-4):163-5. PubMed ID: 4281617
    [No Abstract]   [Full Text] [Related]  

  • 29. The modulating effect of cholera enterotoxin on the immune response.
    Chisari FV; Northrup RS; Chen LC
    J Immunol; 1974 Sep; 113(3):729-39. PubMed ID: 4370486
    [No Abstract]   [Full Text] [Related]  

  • 30. The lipid A immunity system. I. Induction of heterophile antibodies by enterobacterial lipopolysaccharides and their lipid A component.
    Rank WR; DiPauli R; Flügge-Rank U
    Eur J Immunol; 1972 Dec; 2(6):517-22. PubMed ID: 4569996
    [No Abstract]   [Full Text] [Related]  

  • 31. [Determination of the cellular immune response with the aid of a bacterial indicator system].
    Schlewinski E; Luhmer I; Raettig H
    Zentralbl Bakteriol Orig A; 1974; 227(1-4):222-7. PubMed ID: 4154589
    [No Abstract]   [Full Text] [Related]  

  • 32. Functional symmetry amongst daughter cells arising in vitro from single antibody-forming cells.
    Nossal GJ; Lewis H
    Immunology; 1971 May; 20(5):739-53. PubMed ID: 4950858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The primary and secondary antibody response to Escherichia coli O6 lipopolysaccharide analysed at the humoral and cellular level. Amount and avidity of the antibodies in relation to protective capacity.
    Ahlstedt S; Holmgren J; Hanson LA
    Immunology; 1973 Feb; 24(2):191-202. PubMed ID: 4571425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The production of antibody by bursal lymphocytes.
    Waltenbaugh CR; Van Alten PJ
    J Immunol; 1974 Oct; 113(4):1079-84. PubMed ID: 4607223
    [No Abstract]   [Full Text] [Related]  

  • 35. Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli.
    Roland KL; Cloninger C; Kochi SK; Thomas LJ; Tinge SA; Rouskey C; Killeen KP
    Vaccine; 2007 Dec; 25(51):8574-84. PubMed ID: 18045752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular formation of viriolytic antibody by mouse immunocytes: cytokinetics and specificity.
    McAlack RF; Cerny J; Friedman H
    J Immunol; 1971 Dec; 107(6):1752-65. PubMed ID: 4941115
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of plasmacytomas on the immune response of mice.
    Zolla S
    J Immunol; 1972 Apr; 108(4):1039-48. PubMed ID: 4554010
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of erythrocytes sensitized with purified enterotoxin from Vibrio cholerae for the assay of antibody and antibody-forming cells.
    Kateley JR; Friedman H
    J Infect Dis; 1975 Feb; 131(2):144-8. PubMed ID: 1090686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Friend leukemogenic virus on antibody-forming cells to a bacterial somatic antigen.
    Hirano S; Ceglowski WS; Allen JL; Friedman H
    J Natl Cancer Inst; 1969 Dec; 43(6):1337-45. PubMed ID: 4918854
    [No Abstract]   [Full Text] [Related]  

  • 40. Stimulation of cAMP levels and modulation of antibody formation in mice immunized with cholera toxin.
    Kateley JR; Friedman H
    Ann N Y Acad Sci; 1975 Feb; 249():413-23. PubMed ID: 165769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.